Яз
Pajjiż: Iżrael
Lingwa: Russu
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
DROSPIRENONE 3 MG; ETHINYLESTRADIOL 0.02 MG
Disponibbli minn:
BAYER ISRAEL LTD
Kodiċi ATC:
G03AA12
Għamla farmaċewtika:
FILM COATED TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
BAYER WEIMAR GMBH UND CO.KG, GERMANY
Grupp terapewtiku:
DROSPIRENONE AND ESTROGEN
Indikazzjonijiet terapewtiċi:
- Oral contraception. - Treatment of moderate acne vulgaris in women who seek oral contraception. - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Yaz for PMDD was not assessed beyond 3 cycles. Yaz has not been evaluated for treatment of PMS ( premenstrual syndrome ).
Data ta 'l-awtorizzazzjoni:
2009-07-01
